ReviewNutritional approaches in the risk reduction and management of Alzheimer's disease
Introduction
Alzheimer's disease (AD), the most common form of dementia, is estimated to reach 100 million cases worldwide by 2050 [1], [2]. It imposes a significant burden on patients, caregivers, and health care systems—the estimate in the United States alone is for an increase in health care budget for AD and other dementias from $200 billion in 2012 to $1.1 trillion in 2050 [3]. Thus, more effective therapies and novel strategies leading to improved disease management or risk reduction would have enormous socioeconomic effect.
Although AD was first identified more than 100 y ago, mechanistic studies and therapeutic developments for this devastating disease have gained momentum mostly in the past 30 y. Extraneuronal senile plaques and intraneuronal neurofibrillary tangles are two hallmarks of disease pathology in AD brain. Clinical manifestations include cognitive impairment and dementia. However, more subtle synaptic changes may occur years before such pathological and clinical symptoms manifest. Such a continuum of synaptic loss is strongly correlated with cognitive impairment [4], [5], [6], [7]. With the recent advance in methodologies and techniques for early diagnosis of AD, especially the continuing maturation of structural, functional, and molecular imaging (i.e., magnetic resonance imaging [MRI], positron emission tomography [PET] or single-photon emission computed tomography [SPECT]) and identification of reliable cerebrospinal fluid (CSF)/plasma biomarkers, the research focus has shifted to the earliest stages of AD and strategies to reduce the risk for disease progression [8].
Mounting evidence points to the important role of nutrition in relation to cognitive function, especially during aging [9]. The maintenance of healthy neurons relies on adequate supply of nutritional compounds, which are mostly acquired from the diet. For instance, docosahexaenoic acid (DHA) from dietary intake is important for the formation of neuronal membranes. Choline is a precursor for the neurotransmitter acetylcholine and it also is used in the synthesis of neuronal membrane. For other nutrients' roles in the structure and function of the nervous system one can refer to a review by Bourre [10]. Furthermore, lower intakes of certain nutrients (i.e., DHA, B vitamins, and antioxidants) have been linked to increasing risk for AD and a diet rich in the aforementioned nutrients has shown to decrease the risk for AD [11], [12], [13], [14]. Hence, in addition to pharmaceutical therapeutic approaches and lifestyle modification, we postulate that nutritional approaches are set to play an important role in future management options for AD. This contribution focuses on nutritional approaches investigated so far and their potentials as risk reduction measures of AD.
Section snippets
Protein-energy malnutrition in AD
Impaired nutritional status has been reported in AD. Protein-energy malnutrition is prevalent at the demented stage of AD and increases with disease severity (Fig. 1). In mild to moderate AD, 3% of the patients were reported to be malnourished [15], whereas another study indicated that 50% of patients with severe AD had protein-energy malnutrition [16]. Such compromised protein-energy status could be due to worsening of appetite, taste, and smell, which lead to reduced food consumption,
Protein-energy supplementation by oral nutritional supplements in AD
Nutritional approaches have been implicated in the management of AD [76]. For instance, oral nutritional supplements (ONS) using protein and energy supplementation have been applied in AD patients at risk for malnutrition in hospital and day-care centers; this resulted in significant improvements in energy intake with ONS versus usual care [77], [78].
Single- or multinutrient approaches in AD
Nutritional interventions using micronutrients/fatty acids targeting cognition so far have shown contrasting results [79]. Although the majority
Preventive initiatives
With the advance of diagnostic methodology and technology, in combination with the understanding of the disease pathogenesis, a paradigm shift to earlier diagnosis and treatment of AD is occurring [79]. Such a paradigm shift is a strategic continuum from disease management in AD, to early diagnosis and treatment in subjects in the prodromal/preclinical stages of AD and eventually to risk reduction in the general aging population. Three ongoing, US-led prevention initiatives have formed a new
Conclusion
Current advances in earlier diagnosis of AD facilitates investigation of the idea that interventions targeting prodromal stage or even earlier stages of AD might be more effective than at more advanced clinical stages, when damaging pathophysioloigical changes may have accumulated to an irreversible degree. Effective, nutrition-based approaches would be of great benefit due to a relatively low risk for side effects in a presymptomatic or prodromal, and relatively healthy population allied to
Acknowledgments
We thank Saskia Elemans for literature search, and Martijn de Wilde and Andrew Lynch for editorial support.
Mi W, van Wijk N, Sijben JWC, Kamphuis PJGH are employees of Nutricia Advanced Medical Nutrition, Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands.
Cansev M has received unrestricted research funding from Nutricia Advanced Medical Nutrition.
References (118)
- et al.
Forecasting the global burden of Alzheimer's disease
Alzheimers Dement
(2007) - et al.
Global prevalence of dementia: a Delphi consensus study
Lancet
(2005) - et al.
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Neurobiol Aging
(2006) - et al.
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Alzheimers Dement
(2011) - et al.
Factors associated with nutritional status in a group of people in an early stage of dementia
Clin Nutr
(2003) - et al.
Tin and fatty acids in dementia
Prostaglandins Leukot Essent Fatty Acids
(1991) - et al.
Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content
Int J Biochem Cell Biol
(1998) - et al.
Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease
J Trace Elem Med Biol
(2010) - et al.
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease
Neurobiol Aging
(2003) - et al.
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
Am J Clin Nutr
(2004)
Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease
Prostaglandins Leukot Essent Fatty Acids
Hyperhomocysteinemia and Alzheimer's disease: a systematic review
Arch Gerontol Geriatr
A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease
Neurobiol Aging
Folate nutriture alters choline status of women and men fed low choline diets
J Nutr
Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally
Brain Res
Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils
Neuroscience
Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat
Brain Res
Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus
Brain Res
Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12
Neuroscience
Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats
Behav Brain Res
Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats
J Nutr
Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats
Neurobiol Learn Mem
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Neuron
Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms
J Biol Chem
Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice
Neurobiol Dis
Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats
J Nutr
The potential role of nutritional components in the management of Alzheimer's disease
Eur J Pharmacol
Utility of imaging for nutritional intervention studies in Alzheimer's disease
J Pharmacology
Effects of omega-3 fatty acids on cognitive performance: a meta-analysis
Neurobiol Aging
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment
Ann Neurol
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Neurology
Alzheimer's disease is a synaptic failure
Science
New insights into nutrition and cognitive neuroscience
Proc Nutr Soc
Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients
J Nutr Health Aging
IANA task force on nutrition and cognitive decline with aging
J Nutr Health Aging
Dietary patterns and risk of dementia: the three-hity cohort study
Neurology
Relation of higher folate intake to lower risk of Alzheimer disease in the elderly
Arch Neurol
The role of nutrition in Alzheimer's disease: epidemiological evidence
Eur J Neurol
Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group)
J Nutr Health Aging
Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multiinfarct dementia
J Am Geriatr Soc
Cognitive function and caregiver burden: predictive factors for eating behaviour disorders in Alzheimer's disease
Int J Geriatr Psychiatry
Behavioral disturbances, not cognitive deterioration, are associated with altered food selection in seniors with Alzheimer's disease
J Gerontol A Biol Sci Med Sci
Weight loss in Alzheimer's disease
Int J Geriatr Psychiatry
Weight loss in people with Alzheimer's disease: a prospective population based analysis
BMJ
Weight loss in Alzheimer disease
Am J Clin Nutr
Use of BMI in the assessment of undernutrition in older subjects: reflecting on practice
Proc Nutr Soc
Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients
Facts Res Gerontol
Plasma nutrient status of Alzheimer's disease patients compared to cognitive intact elderly controls: a systematic review and meta-analysis
Alzheimers Dement, submitted
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
Lipids
Cited by (74)
Improvement of cognitive performance by a nutraceutical formulation: Underlying mechanisms revealed by laboratory studies
2021, Free Radical Biology and MedicineCitation Excerpt :Individuals without dementia but with depressive symptoms but having normal levels of folate and B12 improved in cognitive performance [299]. Unlike current pharmacological agents, nutritional approaches have the potential to positively impact neurodegenerative processes well before manifestation of AD [100,174,193,194]. One-Carbon Metabolism consists of two intersecting pathways: the Transmethylation Pathway and the Transulfuration Pathway (Fig. 1).
Positive effects of folic acid supplementation on cognitive aging are dependent on ω-3 fatty acid status: A post hoc analysis of the FACIT trial
2021, American Journal of Clinical NutritionThe role of modified Mediterranean neuroprotective diet on emotion, cognition, and depression
2021, Functional Foods and Nutraceuticals in Metabolic and Non-communicable DiseasesPrevention of neurodegenerative disorders by nutraceuticals
2021, Nutraceuticals: Efficacy, Safety and ToxicityManagement of Alzheimer’s Disease with nutraceuticals
2020, Nutraceuticals in Brain Health and Beyond